Cargando…

Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition

AcrB is the major multidrug exporter in Escherichia coli. Although several substrate-entrances have been identified, the specificity of these various transport paths remains unclear. Here we present evidence for a substrate channel (channel 3)  from the central cavity of the AcrB trimer, which is co...

Descripción completa

Detalles Bibliográficos
Autores principales: Zwama, Martijn, Yamasaki, Seiji, Nakashima, Ryosuke, Sakurai, Keisuke, Nishino, Kunihiko, Yamaguchi, Akihito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760665/
https://www.ncbi.nlm.nih.gov/pubmed/29317622
http://dx.doi.org/10.1038/s41467-017-02493-1
_version_ 1783291406005043200
author Zwama, Martijn
Yamasaki, Seiji
Nakashima, Ryosuke
Sakurai, Keisuke
Nishino, Kunihiko
Yamaguchi, Akihito
author_facet Zwama, Martijn
Yamasaki, Seiji
Nakashima, Ryosuke
Sakurai, Keisuke
Nishino, Kunihiko
Yamaguchi, Akihito
author_sort Zwama, Martijn
collection PubMed
description AcrB is the major multidrug exporter in Escherichia coli. Although several substrate-entrances have been identified, the specificity of these various transport paths remains unclear. Here we present evidence for a substrate channel (channel 3)  from the central cavity of the AcrB trimer, which is connected directly to the deep pocket without first passing the switch-loop and the proximal pocket . Planar aromatic cations, such as ethidium, prefer channel 3 to channels 1 and 2. The efflux through channel 3 increases by targeted mutations and is not in competition with the export of drugs such as minocycline and erythromycin through channels 1 and 2. A switch-loop mutant, in which the pathway from the proximal to the deep pocket is hindered, can export only channel 3-utilizing drugs. The usage of multiple entrances thus contributes to the recognition and transport of a wide range of drugs with different physicochemical properties.
format Online
Article
Text
id pubmed-5760665
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-57606652018-01-12 Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition Zwama, Martijn Yamasaki, Seiji Nakashima, Ryosuke Sakurai, Keisuke Nishino, Kunihiko Yamaguchi, Akihito Nat Commun Article AcrB is the major multidrug exporter in Escherichia coli. Although several substrate-entrances have been identified, the specificity of these various transport paths remains unclear. Here we present evidence for a substrate channel (channel 3)  from the central cavity of the AcrB trimer, which is connected directly to the deep pocket without first passing the switch-loop and the proximal pocket . Planar aromatic cations, such as ethidium, prefer channel 3 to channels 1 and 2. The efflux through channel 3 increases by targeted mutations and is not in competition with the export of drugs such as minocycline and erythromycin through channels 1 and 2. A switch-loop mutant, in which the pathway from the proximal to the deep pocket is hindered, can export only channel 3-utilizing drugs. The usage of multiple entrances thus contributes to the recognition and transport of a wide range of drugs with different physicochemical properties. Nature Publishing Group UK 2018-01-09 /pmc/articles/PMC5760665/ /pubmed/29317622 http://dx.doi.org/10.1038/s41467-017-02493-1 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Zwama, Martijn
Yamasaki, Seiji
Nakashima, Ryosuke
Sakurai, Keisuke
Nishino, Kunihiko
Yamaguchi, Akihito
Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition
title Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition
title_full Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition
title_fullStr Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition
title_full_unstemmed Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition
title_short Multiple entry pathways within the efflux transporter AcrB contribute to multidrug recognition
title_sort multiple entry pathways within the efflux transporter acrb contribute to multidrug recognition
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760665/
https://www.ncbi.nlm.nih.gov/pubmed/29317622
http://dx.doi.org/10.1038/s41467-017-02493-1
work_keys_str_mv AT zwamamartijn multipleentrypathwayswithintheeffluxtransporteracrbcontributetomultidrugrecognition
AT yamasakiseiji multipleentrypathwayswithintheeffluxtransporteracrbcontributetomultidrugrecognition
AT nakashimaryosuke multipleentrypathwayswithintheeffluxtransporteracrbcontributetomultidrugrecognition
AT sakuraikeisuke multipleentrypathwayswithintheeffluxtransporteracrbcontributetomultidrugrecognition
AT nishinokunihiko multipleentrypathwayswithintheeffluxtransporteracrbcontributetomultidrugrecognition
AT yamaguchiakihito multipleentrypathwayswithintheeffluxtransporteracrbcontributetomultidrugrecognition